Breast cancer

Main Article Content

Eunice López-Muñoz
Fabio Salamanca-Gómez

Keywords

Therapeutics, Prognosis, Diagnosis, Tumor, Biomarkers, Breast Neoplasms

Abstract

Breast cancer is a public health problem in Mexico and the world, being the first cause of cancer death in women. Even though scientific advances have allowed the identification of several risk factors, the use of screening and detection techniques, as well as the therapeutic approach, since breast cancer is a heterogeneous entity, it is necessary to carry out studies that increase the knowledge about its epidemiological, clinical, histopathological and molecular characteristics that allow improving the strategies of prevention, diagnosis, treatment and reduction of complications in order to improve the quality of life and the survival of patients.

Abstract 179 | PDF (Spanish) Downloads 973 HTML (Spanish) Downloads 110

References

1. Cancer.org [Internet]. Atlanta:American Cancer Society;2019 [actualizado en 2019;consultado el 21 de mayo de 2019] [aprox. 2 pantallas]. Disponible en https://www.cancer.org/cancer/cancer-basics/history-of-cancer/what-is-cancer.html

2. Das M, Miyakawa T, Fox CF, Pruss RM, Aharonov A, Herschman HR. Specific radiolabeling of a cell surface receptor for epidermal growth factor. Proc Natl Acad Sci U S A. 1977;74(7):2790-4. doi:10.1073/pnas.74.7.2790

3. González-León M, Fernández-Gárate JE, Rascón-Pacheco RA, Valladares-Aranda MÁ, Dávila-Torres J, Borja-Aburto VH. The burden of disease of cancer in the Mexican Social Security Institute. Salud Publica Mex. 2016;58:132-41.

4. Gallegos-Arreola MP, Figuera LE, Flores-Ramos LG, Puebla-Pérez AM, Zúñiga-González GM. Association of the Alu insertion polymorphism in the progesterone receptor gene with breast cancer in a Mexican population. Arch Med Sci 2015;11:551-60. doi:10.5114/aoms.2015.52357

5. Gutierrez-Rubio SA, Quintero-Ramos A, Durán-Cárdenas A, Franco-Topete RA, Castro-Cervantes JM, Oceguera-Villanueva A, et al. 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients. Genet Mol Res. 2015;14:1250-9. doi:10.4238/2015

6. World Cancer Research Fund/American Institute for Cancer Research (AICR). Food, Nutrition, Physical Activity, and the Prevention of Cancer:A Global Perspective. Washington, DC:AICR;2007.

7. Rodríguez-Cuevas S, Macías Martínez CG, Labastida Almendaro S. [Breast cancer in Mexico. Is it a young women disease?] [artículo en español] Ginecol Obstet Mex. 2000;68:185-90.

8. Banys-Paluchowski M, Krawczyk N, Fehm T. Potential role of circulating tumor cell detection and monitoring in breast cancer:a review of current evidence. Front Oncol. 2016;6:255. doi:10.3389/fonc.2016.00255

9. Haick H, Broza YY, Mochalski P, Ruzsanyi V, Amann A. Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev. 2014;43(5):1423-49. doi:10.1039/c3cs60329f

10. García N, Salamanca F, Astudillo-de la vega H, Curiel-Quesada E, Alvarado I, Peñaloza R, et al. A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. BMC Cancer 2005;5:93. doi:10.1186/1471-2407-5-93